NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
Innovotech Inc. Q3 2025 Financial Results and Business Overview FAQ
TL;DR
Innovotech's record Q3-2025 revenue and net income position investors to capitalize on growing antimicrobial research and pharmaceutical testing market demand.
Innovotech achieved $1,267,692 Q3 revenue through antimicrobial contract research, Keystone Labs analytical services, and increased product sales across its diversified portfolio.
Innovotech's antimicrobial solutions and pharmaceutical testing services contribute to public health by advancing infection control and medication safety for communities worldwide.
Innovotech's 60% stake in NouLifeSciences explores antioxidant molecules for cosmetics and neuropathies while delivering record financial performance.
Found this article helpful?
Share it with your network and spread the knowledge!
Innovotech generated record Q3-2025 revenue of $1,267,692 with net income of $92,945, and year-to-date revenue of $3,410,204 as of November 4, 2025.
Revenue growth was driven by increasing demand for antimicrobial contract research services, strong performance from analytical services through Keystone Labs, and higher product sales.
Craig Milne is the CEO, who stated that the company has been building a foundation for continued growth and is pleased to see financial performance reflecting the changes underway.
Innovotech is a diversified Canadian technology company with operations in specialized laboratory services, biotechnology businesses, and proprietary intellectual property, managing several subsidiary companies.
Innovotech Labs Corporation provides antimicrobial testing services and commercializes antimicrobial silver solutions, Keystone Labs Inc. is a DEL-accredited lab serving pharmaceutical and industrial markets, and Innovotech owns 60% of NouLifeSciences Inc., which holds antioxidant molecule intellectual property.
The company is based in Edmonton, Alberta, Canada and is listed on the TSX Venture Exchange under the symbol IOT.
NouLifeSciences holds intellectual property related to antioxidant molecules with potential applications in cosmetics and various medical conditions including neuropathies.
Risks include regulatory environment challenges, currency fluctuations, reliance on few customers including government organizations, operating result fluctuations, government policies, clinical trial costs, strategic relationship dependencies, intellectual property protection issues, and potential lawsuits.
Contact Craig Milne, CEO, at +1-604-239-1819 or craig.milne@innovotech.ca for more information about the company.
Visit www.innovotech.ca for Innovotech information and www.keystonelabs.ca for Keystone Labs details.
Curated from NewMediaWire
